Eli Lilly's lepodisiran met Phase 2 trial goals, significantly lowering Lp(a) levels. A Phase 3 study is enrolling to assess ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits and consistent safety data.

This study tested whether IMRS is associated with clinical morbidity endpoints. Conclusion Intermountain Risk Score, a predictor of mortality, was associated with morbidity endpoints that often ...

EDMONTON, AB, March 26, 2025 /CNW/ - ATB Investment Management Inc. ("ATBIM") announced a risk rating change for Compass Maximum Growth Portfolio that will take effect today and be reflected in ...